16.07.2013 • NewsDede WillamsFrackinghydraulic fracturing

France’s Holland Rules Out Fracking at Least Until 2017

French president Francois Hollande has ruled out overturning the country's ban on hydraulic fracturing, or fracking, during his five-year term of office, which ends in 2017. The president's remarks were made during a television interview on Bastille Day, France's national holiday, on July 14. The ban has been in place since 2011.

Hollande's remarks came only days before the country's highest court was due to begin hearing a challenge to the ban brought by Schuepbach Energy of Dallas, Texas; www.schuepbachenergy.com). The company owned by a former U.S. oil executive and private equity funds was left holding two fracking permits it was unable to use when the ban was pronounced. "As long as I am president, there will be no exploration for shale gas in France," Hollande affirmed.

The International Energy Agency (IEA) believes that France has some of Europe's biggest shale gas deposits. (dw)

 

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.